Lymphocyte adhesion to high endothelium is mediated by two beta 1 integrin receptors for fibronectin, alpha 4 beta 1 and alpha 5 beta 1.

PubWeight™: 0.87‹?›

🔗 View Article (PMID 1388178)

Published in J Cell Sci on April 01, 1992

Authors

Z Szekanecz1, M J Humphries, A Ager

Author Affiliations

1: 3rd Department of Medicine, University Medical School of Debrecen, Hungary.

Articles by these authors

Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin. J Cell Biol (1989) 5.69

Mental health in complex emergencies. Lancet (2004) 2.97

A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science (1986) 2.91

Deaths occurring in newly notified patients with pulmonary tuberculosis in England and Wales. Br J Dis Chest (1984) 2.71

PKCalpha regulates beta1 integrin-dependent cell motility through association and control of integrin traffic. EMBO J (1999) 2.66

Identification of an alternatively spliced site in human plasma fibronectin that mediates cell type-specific adhesion. J Cell Biol (1986) 2.63

Identification of two distinct regions of the type III connecting segment of human plasma fibronectin that promote cell type-specific adhesion. J Biol Chem (1987) 2.52

Cooperative signaling by alpha 5 beta 1 and alpha 4 beta 1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin. J Cell Biol (1995) 2.45

Regulation of integrin alpha 5 beta 1-fibronectin interactions by divalent cations. Evidence for distinct classes of binding sites for Mn2+, Mg2+, and Ca2+. J Biol Chem (1995) 2.35

The minimal essential sequence for a major cell type-specific adhesion site (CS1) within the alternatively spliced type III connecting segment domain of fibronectin is leucine-aspartic acid-valine. J Biol Chem (1991) 2.08

Affinity chromatographic isolation of the melanoma adhesion receptor for the IIICS region of fibronectin and its identification as the integrin alpha 4 beta 1. J Biol Chem (1990) 2.08

VLA-4 mediates CD3-dependent CD4+ T cell activation via the CS1 alternatively spliced domain of fibronectin. J Exp Med (1990) 1.95

Bone and joint tuberculosis. A survey of notifications in England and Wales. J Bone Joint Surg Br (1984) 1.93

Defining the topology of integrin alpha5beta1-fibronectin interactions using inhibitory anti-alpha5 and anti-beta1 monoclonal antibodies. Evidence that the synergy sequence of fibronectin is recognized by the amino-terminal repeats of the alpha5 subunit. J Biol Chem (1997) 1.87

Crystal structure of a heparin- and integrin-binding segment of human fibronectin. EMBO J (1999) 1.84

Differential effects of hydrogen peroxide on indices of endothelial cell function. J Exp Med (1984) 1.72

Requirement for Rho in integrin signalling. Cell Adhes Commun (1997) 1.66

The cell-binding domain of intimin from enteropathogenic Escherichia coli binds to beta1 integrins. J Biol Chem (1996) 1.64

Attachment, spreading and locomotion of avian neural crest cells are mediated by multiple adhesion sites on fibronectin molecules. EMBO J (1988) 1.62

Metalloproteinase-mediated regulation of L-selectin levels on leucocytes. J Biol Chem (1996) 1.55

Effects of isolation and culture on prostaglandin synthesis by porcine aortic endothelial and smooth muscle cells. J Cell Physiol (1982) 1.55

The CS5 peptide is a second site in the IIICS region of fibronectin recognized by the integrin alpha 4 beta 1. Inhibition of alpha 4 beta 1 function by RGD peptide homologues. J Biol Chem (1991) 1.54

Identification of a novel anti-integrin monoclonal antibody that recognises a ligand-induced binding site epitope on the beta 1 subunit. FEBS Lett (1995) 1.54

PKCdelta is required for mitochondrial-dependent apoptosis in salivary epithelial cells. J Biol Chem (2001) 1.54

The inhibitory anti-beta1 integrin monoclonal antibody 13 recognizes an epitope that is attenuated by ligand occupancy. Evidence for allosteric inhibition of integrin function. J Biol Chem (1996) 1.47

Symptomatic intracranial tuberculoma developing during treatment of tuberculosis: a report of 10 patients and review of the literature. Q J Med (1987) 1.47

Diagnosis of tuberculous meningitis by detection of tuberculostearic acid in cerebrospinal fluid. Lancet (1987) 1.38

Recent advances in research on fibronectin and other cell attachment proteins. J Cell Biochem (1985) 1.38

Oligosaccharide modification by swainsonine treatment inhibits pulmonary colonization by B16-F10 murine melanoma cells. Proc Natl Acad Sci U S A (1986) 1.37

Integrin alpha 4 beta 1-mediated melanoma cell adhesion and migration on vascular cell adhesion molecule-1 (VCAM-1) and the alternatively spliced IIICS region of fibronectin. J Biol Chem (1994) 1.34

Alpha 6 integrins are required for Langerhans cell migration from the epidermis. J Exp Med (1997) 1.32

Identification of a novel recognition sequence for the integrin alpha 4 beta 1 in the COOH-terminal heparin-binding domain of fibronectin. EMBO J (1991) 1.31

Heterogeneity in endothelial cells from large vessels and microvessels. Differentiation (1987) 1.31

Regulation of integrin function: evidence that bivalent-cation-induced conformational changes lead to the unmasking of ligand-binding sites within integrin alpha5 beta1. Biochem J (1998) 1.29

Competitive binding of vascular cell adhesion molecule-1 and the HepII/IIICS domain of fibronectin to the integrin alpha 4 beta 1. J Biol Chem (1994) 1.29

Molecular basis of ligand recognition by integrin alpha 5beta 1. I. Specificity of ligand binding is determined by amino acid sequences in the second and third NH2-terminal repeats of the alpha subunit. J Biol Chem (2000) 1.29

Extra-pulmonary tuberculosis. Br Med Bull (1988) 1.28

Generation of a minimal alpha5beta1 integrin-Fc fragment. J Biol Chem (2001) 1.28

Tissue inhibitor of metalloproteinases-3 inhibits shedding of L-selectin from leukocytes. J Biol Chem (1999) 1.27

Integrin alpha 2 I-domain is a binding site for collagens. J Cell Sci (1995) 1.24

Field evaluation of the Determine rapid human immunodeficiency virus diagnostic test in Honduras and the Dominican Republic. J Clin Microbiol (1999) 1.22

Studies of lymphocyte transendothelial migration: analysis of migrated cell phenotypes with regard to CD31 (PECAM-1), CD45RA and CD45RO. Immunology (1993) 1.22

Measuring violence against women amidst war and displacement in northern Uganda using the "neighbourhood method". J Epidemiol Community Health (2009) 1.22

Molecular basis of ligand recognition by integrin alpha5beta 1. II. Specificity of arg-gly-Asp binding is determined by Trp157 OF THE alpha subunit. J Biol Chem (2000) 1.15

Cerebrospinal fluid drug concentrations and the treatment of tuberculous meningitis. Am Rev Respir Dis (1993) 1.14

ICAMs redistributed by chemokines to cellular uropods as a mechanism for recruitment of T lymphocytes. J Cell Biol (1997) 1.13

Inhibition of experimental metastasis by castanospermine in mice: blockage of two distinct stages of tumor colonization by oligosaccharide processing inhibitors. Cancer Res (1986) 1.12

Identification of a novel heparin-binding site in the alternatively spliced IIICS region of fibronectin: roles of integrins and proteoglycans in cell adhesion to fibronectin splice variants. Matrix Biol (2001) 1.11

Alpha4 integrin binding interfaces on VCAM-1 and MAdCAM-1. Integrin binding footprints identify accessory binding sites that play a role in integrin specificity. J Biol Chem (1997) 1.11

A structure prediction for the ligand-binding region of the integrin beta subunit: evidence for the presence of a von Willebrand factor A domain. FEBS Lett (1997) 1.11

ICAM-1-independent lymphocyte transmigration across high endothelium: differential up-regulation by interferon gamma, tumor necrosis factor-alpha and interleukin 1 beta. Eur J Immunol (1992) 1.11

L-selectin shedding does not regulate human neutrophil attachment, rolling, or transmigration across human vascular endothelium in vitro. J Immunol (1997) 1.10

Identification of heparin as a ligand for the A-domain of Plasmodium falciparum thrombospondin-related adhesion protein. Mol Biochem Parasitol (1999) 1.10

Fibronectin is a survival factor for differentiated osteoblasts. J Cell Sci (1998) 1.10

Indicator microbes correlate with pathogenic bacteria, yeasts and helminthes in sand at a subtropical recreational beach site. J Appl Microbiol (2011) 1.09

Penetration of pyrazinamide into the cerebrospinal fluid in tuberculous meningitis. Br Med J (Clin Res Ed) (1987) 1.09

Fine mapping of inhibitory anti-alpha5 monoclonal antibody epitopes that differentially affect integrin-ligand binding. Biochem J (1999) 1.09

Identification of a key integrin-binding sequence in VCAM-1 homologous to the LDV active site in fibronectin. J Cell Sci (1994) 1.09

Homology modelling of integrin EF-hands. Evidence for widespread use of a conserved cation-binding site. Biochem J (1992) 1.08

Effects of collagenase-cleavage of type I collagen on alpha2beta1 integrin-mediated cell adhesion. J Cell Sci (1998) 1.08

VCAM-1 is a CS1 peptide-inhibitable adhesion molecule expressed by lymph node high endothelium. J Cell Sci (1993) 1.08

The integrin alpha1 A-domain is a ligand binding site for collagens and laminin. J Biol Chem (1997) 1.07

An RGD to LDV motif conversion within the disintegrin kistrin generates an integrin antagonist that retains potency but exhibits altered receptor specificity. Evidence for a functional equivalence of acidic integrin-binding motifs. J Biol Chem (1997) 1.07

Foot-and-mouth disease virus is a ligand for the high-affinity binding conformation of integrin alpha5beta1: influence of the leucine residue within the RGDL motif on selectivity of integrin binding. J Gen Virol (2000) 1.06

Surface loops adjacent to the cation-binding site of the complement factor B von Willebrand factor type A module determine C3b binding specificity. Biochemistry (1997) 1.06

Field evaluation of the OptiMAL rapid malaria diagnostic test during anti-malarial therapy in Guyana. Trans R Soc Trop Med Hyg (2000) 1.05

Human natural killer cells express VLA-4 and VLA-5, which mediate their adhesion to fibronectin. J Immunol (1991) 1.05

beta1-integrin cytoplasmic subdomains involved in dominant negative function. Mol Biol Cell (1998) 1.05

Conformation dependence of integrin-type II collagen binding. Inability of collagen peptides to support alpha 2 beta 1 binding, and mediation of adhesion to denatured collagen by a novel alpha 5 beta 1-fibronectin bridge. J Cell Sci (1994) 1.04

Integrin antagonists. Cell Mol Life Sci (1999) 1.04

The nature of the active species in bis(imino)pyridyl cobalt ethylene polymerisation catalysts. Chem Commun (Camb) (2001) 1.03

Transendothelial migration of lymphocytes across high endothelial venules into lymph nodes is affected by metalloproteinases. Blood (2001) 1.03

Stimulation of DNA synthesis by cathepsin D digests of fibronectin. Nature (1983) 1.02

Involvement of a metalloprotease in the shedding of human neutrophil Fc gammaRIIIB. FEBS Lett (1997) 1.02

Elucidation of the structural features of heparan sulfate important for interaction with the Hep-2 domain of fibronectin. J Biol Chem (2000) 1.01

The alpha 4 integrin chain is a ligand for alpha 4 beta 7 and alpha 4 beta 1. J Exp Med (1995) 1.01

Collagen can modulate cell interactions with fibronectin. J Cell Biol (1985) 1.01

Effects of neutrophil elastase and other proteases on porcine aortic endothelial prostaglandin I2 production, adenine nucleotide release, and responses to vasoactive agents. J Clin Invest (1984) 0.99

To what behaviors do attending adults respond? A replication. Am J Ment Defic (1987) 0.99

The integrin beta subunit. Int J Biochem Cell Biol (1998) 0.99

Activity of azithromycin as a blood schizonticide against rodent and human plasmodia in vivo. Am J Trop Med Hyg (1995) 0.98

Analysis of ligand-induced and ligand-attenuated epitopes on the leukocyte integrin alpha4beta1: VCAM-1, mucosal addressin cell adhesion molecule-1, and fibronectin induce distinct conformational changes. J Immunol (1998) 0.97

Integrin adhesion receptors: structure, function and implications for biomedicine. Mol Med Today (1996) 0.96

The effect of alpha4 beta1-integrin binding sequences of fibronectin on growth of cells from human hematopoietic progenitors. Blood (1998) 0.96

Interactions between interleukin-2-activated lymphocytes and vascular endothelium: binding to and migration across specialized and non-specialized endothelia. Immunology (1992) 0.95

Use of synthetic peptides to probe lymphocyte--high endothelial cell interactions. Lymphocytes recognize a ligand on the endothelial surface which contains the CS1 adhesion motif. Int Immunol (1990) 0.95

Identification of amino acid residues that form part of the ligand-binding pocket of integrin alpha5 beta1. J Biol Chem (1998) 0.95

Amino acid motifs required for isolated beta cytoplasmic domains to regulate 'in trans' beta1 integrin conformation and function in cell attachment. J Cell Sci (1999) 0.95

Palliative versus curative beliefs regarding tropical epilepsy as a function of traditional and medical attributions. Cent Afr J Med (1993) 0.94

Lymphocyte migration across high endothelium is associated with increases in alpha 4 beta 1 integrin (VLA-4) affinity. J Cell Sci (1993) 0.94

Changes in the fibronectin-specific integrin expression pattern modify the migratory behavior of sarcoma S180 cells in vitro and in the embryonic environment. J Cell Biol (1995) 0.92

Roles of alpha(4) integrins/VCAM-1 and LFA-1/ICAM-1 in the binding and transendothelial migration of T lymphocytes and T lymphoblasts across high endothelial venules. Int Immunol (2000) 0.92

A secondary structure model of the integrin alpha subunit N-terminal domain based on analysis of multiple alignments. Cell Adhes Commun (1994) 0.90

Conformation-dependent platelet adhesion to collagen involving integrin alpha 2 beta 1-mediated and other mechanisms: multiple alpha 2 beta 1-recognition sites in collagen type I. Biochem J (1994) 0.90

Regulation of the extracellular ligand binding activity of integrins. Front Biosci (1998) 0.89

Association between receptor density, cellular activation, and transformation of adhesive behavior of flowing lymphocytes binding to VCAM-1. Eur J Immunol (1997) 0.89

Integrins: a review of their structure and mechanisms of ligand binding. Symp Soc Exp Biol (1993) 0.89

Time-course of adhesion molecule expression in rectal mucosa of gluten-sensitive subjects after gluten challenge. Clin Exp Immunol (1993) 0.88

Migration pathways of CD4 T cell subsets in vivo: the CD45RC- subset enters the thymus via alpha 4 integrin-VCAM-1 interaction. Int Immunol (1995) 0.87